Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Fine

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Oncotarget|April 29, 2017
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancerMark Yarchoan, Melinda C Myzak, Burles A Johnson, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancerDung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Oncogene|March 12, 2003
Preferential induction of necrosis in human breast cancer cells by a p53 peptide derived from the MDM2 binding siteTamara N Do, Ramon V Rosal, Lisa Drew, et al.
Oncotarget|April 29, 2017
Olaparib in combination with irinotecan, cisplatin, and mitomycin C in patients with advanced pancreatic cancerMark Yarchoan, Melinda C Myzak, Burles A Johnson, et al.
Cancer Chemotherapy and Pharmacology|February 2, 2013
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experienceRobert L Fine, Anthony P Gulati, Benjamin A Krantz, et al.
Cancer Chemotherapy and Pharmacology|August 10, 2006
Androgen and c-Kit receptors in desmoplastic small round cell tumors resistant to chemotherapy: novel targets for therapyRobert L Fine, Samir S Shah, Thomas A Moulton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 14, 2015
Safety and survival with GVAX pancreas prime and Listeria Monocytogenes-expressing mesothelin (CRS-207) boost vaccines for metastatic pancreatic cancerDung T Le, Andrea Wang-Gillam, Vincent Picozzi, et al.
Pageof 7